Wordt geladen...
Women With Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
BACKGROUND: Identifying DCIS patients at low risk for disease progression could obviate need for standard therapy. The LORIS (surgery versus active monitoring for low-risk DCIS) trial is studying the safety of monitoring low-risk DCIS, although ipsilateral breast tumor recurrence (IBTR) rates in pat...
Bewaard in:
| Gepubliceerd in: | Ann Surg Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5167359/ https://ncbi.nlm.nih.gov/pubmed/27766556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5595-3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|